Full Press Release Details
[et_pb_section fb_built=”1″ fullwidth=”on” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_fullwidth_code _builder_version=”4.27.4″ _module_preset=”default” custom_css_free_form=”.breadcrumbs {|| position: fixed;|| left: 0;|| right: 0;|| z-index: 1000;|| display: flex;|| justify-content: center;|| padding: 0 24px;||}||||.breadcrumbs .breadcrumbContainer {|| width: 100%;|| max-width: 1110px;|| margin: 0 auto; || position: relative;||}||||.container {|| width:100% !important;|| padding-top:80px !important||}||.breadcrumbs::after {|| content: %22%22;|| height: 100%;|| width: 135px;|| background: linear-gradient(to left, rgba(255, 255, 255, 1), rgba(255, 255, 255, 0));|| position: absolute;|| right: 0;|| top: 0;||}||||@media (min-width: 1200px) {|| .breadcrumbs .breadcrumbContainer {|| max-width: 1110px;|| }||}||||@media (max-width: 1199px) and (min-width: 992px) {|| .breadcrumbs .breadcrumbContainer {|| max-width: 960px;|| }||}||||@media (max-width: 991px) and (min-width: 768px) {|| .breadcrumbs .breadcrumbContainer{|| max-width: 720px;|| }||}||||@media (max-width: 767px) and (min-width: 576px) {|| .breadcrumbs .breadcrumbContainer {|| max-width: 540px;|| }||}||||@media (max-width: 575px) {|| .breadcrumbs .breadcrumbContainer {|| max-width: 100%;|| }||}” global_colors_info=”{}”] Home CG Oncology to Present… [/et_pb_fullwidth_code][/et_pb_section][et_pb_section fb_built=”1″ module_id=”pressReleasesWrapper” _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”-100px||||false|false” custom_padding=”0px||||false|false” global_colors_info=”{}”][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”15px||||false|false” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_heading title=”PRESS RELEASE” module_class=”press-inner-title” _builder_version=”4.27.4″ _module_preset=”default” title_font=”Montserrat|700|||||||” title_text_align=”left” title_text_color=”#2b7de1″ width_tablet=”” width_phone=”276px” width_last_edited=”on|phone” height_tablet=”” height_phone=”34px” height_last_edited=”on|phone” custom_margin=”||||false|false” custom_margin_tablet=”||||false|false” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” custom_padding=”||||false|false” global_colors_info=”{}”][/et_pb_heading][et_pb_text content_tablet=”CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference” content_phone=”CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference” content_last_edited=”on|phone” _builder_version=”4.27.5″ _module_preset=”default” text_font=”Montserrat|700|||||||” text_text_color=”#002169″ text_font_size=”24px” text_line_height=”1.3em” width=”1010px” width_tablet=”1010px” width_phone=”328px” width_last_edited=”on|phone” height=”93px” height_tablet=”93px” height_phone=”317px” height_last_edited=”on|phone” custom_margin_tablet=”” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” text_line_height_tablet=”” text_line_height_phone=”1.3em” text_line_height_last_edited=”on|desktop” global_colors_info=”{}”]CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row module_class=”audio-player-wrapper” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]
Listen to this article now
[/et_pb_text][et_pb_code _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”] [/et_pb_code][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”0px||||false|false” custom_margin_tablet=”-50px||||false|false” custom_margin_phone=”0px||||false|false” custom_margin_last_edited=”on|phone” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”-30px||||false|false” custom_margin_tablet=”-30px||||false|false” custom_margin_phone=”-30px||||false|false” custom_margin_last_edited=”on|desktop” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text content_tablet=”IRVINE, Calif., February 23, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will present at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 3:10 pm ET. The conference is taking place at the Boston Marriott Copley Place in Boston, MA.
Interested parties may access the live audio webcast for this conference from the Investor Relations section of the company’s website at www.cgoncology.com . The webcast replay will be available shortly after the conclusion of the live presentation and archived for approximately 90 days.” content_phone=”IRVINE, Calif., February 23, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will present at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 3:10 pm ET. The conference is taking place at the Boston Marriott Copley Place in Boston, MA.
Interested parties may access the live audio webcast for this conference from the Investor Relations section of the company’s website at www.cgoncology.com . The webcast replay will be available shortly after the conclusion of the live presentation and archived for approximately 90 days.” content_last_edited=”on|phone” _builder_version=”4.27.5″ _module_preset=”default” text_font=”Montserrat||||||||” text_text_color=”#000000″ text_font_size=”18px” width_tablet=”” width_phone=”329px” width_last_edited=”on|phone” height_tablet=”” height_phone=”2950px” height_last_edited=”on|phone” custom_margin_tablet=”” custom_margin_phone=”-80px||||false|false” custom_margin_last_edited=”on|phone” global_colors_info=”{}”]IRVINE, Calif., February 23, 2026 (GLOBE NEWSWIRE) — CG Oncology, Inc. (NASDAQ: CGON) today announced that Arthur Kuan, Chairman & Chief Executive Officer, and Ambaw Bellete, President & Chief Operating Officer, will present at the TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026, at 3:10 pm ET. The conference is taking place at the Boston Marriott Copley Place in Boston, MA.
Interested parties may access the live audio webcast for this conference from the Investor Relations section of the company’s website at www.cgoncology.com . The webcast replay will be available shortly after the conclusion of the live presentation and archived for approximately 90 days.[/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”-30px||||false|false” custom_margin_tablet=”-30px||||false|false” custom_margin_phone=”-30px||||false|false” custom_margin_last_edited=”on|phone” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_text content_tablet=” About CG Oncology CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com .
CONTACTS: Media Sarah Connors Vice President, Communications and Patient Advocacy, CG Oncology sarah.connors@cgoncology.com
Investor Relations Megan Knight Vice President, Investor Relations, CG Oncology megan.knight@cgoncology.com ” content_phone=” About CG Oncology CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com .
CONTACTS: Media Sarah Connors Vice President, Communications and Patient Advocacy, CG Oncology sarah.connors@cgoncology.com
Investor Relations Megan Knight Vice President, Investor Relations, CG Oncology megan.knight@cgoncology.com ” content_last_edited=”on|phone” _builder_version=”4.27.5″ _module_preset=”default” text_font=”Montserrat||||||||” text_text_color=”#000000″ text_font_size=”18px” width_tablet=”” width_phone=”326px” width_last_edited=”on|phone” custom_margin_tablet=”” custom_margin_phone=”-250px||||false|false” custom_margin_last_edited=”on|phone” global_colors_info=”{}”] About CG Oncology CG Oncology is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. CG Oncology sees a world where urologic cancer patients may benefit from our innovative immunotherapies to live with dignity and have an enhanced quality of life. To learn more, please visit: www.cgoncology.com .
CONTACTS: Media Sarah Connors Vice President, Communications and Patient Advocacy, CG Oncology sarah.connors@cgoncology.com
Investor Relations Megan Knight Vice President, Investor Relations, CG Oncology megan.knight@cgoncology.com [/et_pb_text][/et_pb_column][/et_pb_row][et_pb_row module_class=”cta-wrapper-row” _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”-30px||||false|false” custom_css_free_form=” .et_post_meta_wrapper{|| display: none;||}” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”][et_pb_divider color=”#ff5100″ module_class=”divider-container” _builder_version=”4.27.4″ _module_preset=”default” custom_margin=”50px||||false|false” custom_margin_tablet=”” custom_margin_phone=”||||false|false” custom_margin_last_edited=”on|phone” global_colors_info=”{}”][/et_pb_divider][et_pb_code module_class=”cta-wrapper” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}”]
Stay Informed Stay Informed
[/et_pb_code][et_pb_code disabled_on=”on|off|off” _builder_version=”4.27.5″ _module_preset=”default” global_colors_info=”{}”]
[/et_pb_code][/et_pb_column][/et_pb_row][/et_pb_section]